Longevity Health Inc. (XAGE)
0.16
-0.02 (-10.06%)
At close: Apr 16, 2025, 3:59 PM
0.17
5.43%
After-hours: Apr 16, 2025, 07:28 PM EDT
-10.06% (1D)
| Bid | 0.16 |
| Market Cap | 4.77M |
| Revenue (ttm) | 50.32K |
| Net Income (ttm) | -11.9M |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -0.32 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.16 |
| Volume | 2,156,739 |
| Avg. Volume (20D) | 6,358,939 |
| Open | 0.16 |
| Previous Close | 0.18 |
| Day's Range | 0.16 - 0.17 |
| 52-Week Range | 0.10 - 2.93 |
| Beta | 0.76 |
About XAGE
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 23, 2021
Employees 15
Stock Exchange NASDAQ
Ticker Symbol XAGE
2 days ago
+63.2%
Longevity Health Holdings shares are trading highe...
Unlock content with
Pro Subscription